{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T05:22:28Z","timestamp":1787808148501,"version":"build-2784847793"},"reference-count":17,"publisher":"Oxford University Press (OUP)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2005,3,1]]},"DOI":"10.1093\/jac\/dki016","type":"journal-article","created":{"date-parts":[[2005,2,11]],"date-time":"2005-02-11T01:17:38Z","timestamp":1108084658000},"page":"387-390","source":"Crossref","is-referenced-by-count":93,"title":["Linezolid in the treatment of Gram-positive prosthetic joint infections"],"prefix":"10.1093","volume":"55","author":[{"given":"Matteo","family":"Bassetti","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Vitale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanna","family":"Melica","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elda","family":"Righi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Di Biagio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luigi","family":"Molfetta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Pipino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mario","family":"Cruciani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dante","family":"Bassetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2005,3]]},"reference":[{"key":"key\n\t\t\t\t20171010160907_R1","doi-asserted-by":"crossref","unstructured":"Lentino, J. R. (2003). Prosthetic joint infections: bane of orthopedists, challenge for infectious disease specialists. Clinical Infectious Diseases36, 1157\u201361.","DOI":"10.1086\/374554"},{"key":"key\n\t\t\t\t20171010160907_R2","doi-asserted-by":"crossref","unstructured":"Brandt, C. M., Duffy, M. C., Berbari, E. F. et al. (1999). Staphylococcus aureus prosthetic joint infection treated with prosthesis removal and delayed reimplantation arthroplasty. Mayo Clinic Proceedings74, 553\u20138.","DOI":"10.4065\/74.6.553"},{"key":"key\n\t\t\t\t20171010160907_R3","doi-asserted-by":"crossref","unstructured":"Kutscha-Lissberg, F., Hebler, U., Muhr, G. et al. (2003). Linezolid penetration into bone and joint tissues infected with methicillin-resistant staphylococci. Antimicrobial Agents and Chemotherapy47, 3964\u20136.","DOI":"10.1128\/AAC.47.12.3964-3966.2003"},{"key":"key\n\t\t\t\t20171010160907_R4","doi-asserted-by":"crossref","unstructured":"Rana, B., Butcher, I., Grigoris, P. et al. (2002). Linezolid penetration into osteo-articular tissues. Journal of Antimicrobial Chemotherapy50, 747\u201350.","DOI":"10.1093\/jac\/dkf207"},{"key":"key\n\t\t\t\t20171010160907_R5","doi-asserted-by":"crossref","unstructured":"Lovering, A. M., Zhang, J., Bannister, G. C. et al. (2002). Penetration of linezolid into bone, fat, muscle and haematoma of patients undergoing routine hip replacement. Journal of Antimicrobial Chemotherapy50, 73\u20137.","DOI":"10.1093\/jac\/dkf066"},{"key":"key\n\t\t\t\t20171010160907_R6","doi-asserted-by":"crossref","unstructured":"Bassetti, M., Di Biagio, A., Cenderello, G. et al. (2001). Linezolid treatment of prosthetic hip infections due to methicillin-resistant Staphylococcus aureus (MRSA). Journal of Infection43, 148\u20139.","DOI":"10.1053\/jinf.2001.0863"},{"key":"key\n\t\t\t\t20171010160907_R7","doi-asserted-by":"crossref","unstructured":"Jover-Saenz, A., Gaite, F. B., Ribelles, A. et al. (2003). Linezolid treatment of total prosthetic knee infection due to methicillin-resistant Staphylococcus epidermidis. Journal of Infection47, 87\u20138.","DOI":"10.1016\/S0163-4453(03)00019-7"},{"key":"key\n\t\t\t\t20171010160907_R8","doi-asserted-by":"crossref","unstructured":"Tenover, F. C., Biddle, J. W. & Lancaster, M. V. (2001). Increasing resistance to vancomycin and other glycopeptides in Staphylococcus aureus. Emerging Infectious Diseases7, 327\u201332.","DOI":"10.3201\/eid0702.010237"},{"key":"key\n\t\t\t\t20171010160907_R9","unstructured":"Davey, P. G., Rowley, D. R. & Phillips, G. (1992). Teicoplanin\u2014home therapy for prosthetic joint infections. European Journal of Surgery Supplement567, 23\u20135."},{"key":"key\n\t\t\t\t20171010160907_R10","doi-asserted-by":"crossref","unstructured":"Darley, E. S. & MacGowan, A. P. (2004). Antibiotic treatment of Gram-positive bone and joint infections. Journal of Antimicrobial Chemotherapy53, 928\u201335.","DOI":"10.1093\/jac\/dkh191"},{"key":"key\n\t\t\t\t20171010160907_R11","doi-asserted-by":"crossref","unstructured":"Greenberg, R. N. (1990). Treatment of bone, joint, and vascular-access-associated gram-positive bacterial infections with teicoplanin. Antimicrobial Agents and Chemotherapy34, 2392\u20137.","DOI":"10.1128\/AAC.34.12.2392"},{"key":"key\n\t\t\t\t20171010160907_R12","doi-asserted-by":"crossref","unstructured":"Wilcox, M., Nathwani, D. & Dryden, M. (2004). Linezolid compared with teicoplanin for the treatment of suspected or proven Gram-positive infections. Journal of Antimicrobial Chemotherapy53, 335\u201344.","DOI":"10.1093\/jac\/dkh088"},{"key":"key\n\t\t\t\t20171010160907_R13","doi-asserted-by":"crossref","unstructured":"Cepeda, J. A., Whitehouse, T., Cooper, B. et al. (2004). Linezolid versus teicoplanin in the treatment of Gram-positive infections in the critically ill: a randomized, double-blind, multicentre study. Journal of Antimicrobial Chemotherapy53, 345\u201355.","DOI":"10.1093\/jac\/dkh048"},{"key":"key\n\t\t\t\t20171010160907_R14","doi-asserted-by":"crossref","unstructured":"Nathwani, D., Li, J. Z., Balan, D. A. et al. (2004). An economic evaluation of a European cohort from a multinational trial of linezolid versus teicoplanin in serious Gram-positive bacterial infections: the importance of treatment setting in evaluating treatment effects. International Journal of Antimicrobial Agents23, 315\u201324.","DOI":"10.1016\/j.ijantimicag.2003.09.020"},{"key":"key\n\t\t\t\t20171010160907_R15","doi-asserted-by":"crossref","unstructured":"Gerson, S. L., Kaplan, S. L., Bruss, J. B. et al. (2002). Hematologic effects of linezolid: summary of clinical experience. Antimicrobial Agents and Chemotherapy46, 2723\u20136.","DOI":"10.1128\/AAC.46.8.2723-2726.2002"},{"key":"key\n\t\t\t\t20171010160907_R16","doi-asserted-by":"crossref","unstructured":"Lee, E., Burger, S., Shah, J. et al. (2003). Linezolid-associated toxic optic neuropathy: a report of 2 cases. Clinical Infectious Diseases37, 1389\u201391.","DOI":"10.1086\/379012"},{"key":"key\n\t\t\t\t20171010160907_R17","doi-asserted-by":"crossref","unstructured":"Rao, N., Ziran, B. H., Wagener, M. M. et al. (2004). Similar hematologic effects of long-term linezolid and vancomycin therapy in a prospective observational study of patients with orthopedic infections. Clinical Infectious Diseases38, 1058\u201364.","DOI":"10.1086\/382356"}],"container-title":["Journal of Antimicrobial Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jac\/article-pdf\/55\/3\/387\/2283171\/dki016.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,10,10]],"date-time":"2017-10-10T22:48:36Z","timestamp":1507675716000},"score":1,"resource":{"primary":{"URL":"http:\/\/academic.oup.com\/jac\/article\/55\/3\/387\/758369\/Linezolid-in-the-treatment-of-Grampositive"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,3,1]]},"references-count":17,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2005,3]]},"published-print":{"date-parts":[[2005,3,1]]}},"URL":"https:\/\/doi.org\/10.1093\/jac\/dki016","relation":{},"ISSN":["1460-2091","0305-7453"],"issn-type":[{"value":"1460-2091","type":"electronic"},{"value":"0305-7453","type":"print"}],"subject":[],"published-other":{"date-parts":[[2005,3]]},"published":{"date-parts":[[2005,3,1]]}}}